Showing results (1-10 of 71) with videos related to
Sort By:
Pageof 8
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 2, 2004
Buprenorphine in the treatment of opioid dependenceEugen Davids, Markus GastparPsychiatrische Praxis|May 28, 2003
[Attention-deficit/hyperactivity disorder and substance abuse]Eugen Davids, Markus GastparProgress in Neuro-Psychopharmacology & Biological Psychiatry|June 14, 2005
Attention deficit hyperactivity disorder and borderline personality disorderEugen Davids, Markus GastparProgress in Neuro-Psychopharmacology & Biological Psychiatry|July 28, 2004
Antipsychotic treatment of psychosis associated with multiple sclerosisEugen Davids, Ulrike Hartwig, Markus GastparProgress in Neuro-Psychopharmacology & Biological Psychiatry|June 2, 2006
Psychotropic drug prescription in a psychiatric university hospital in GermanyEugen Davids, Christine Bunk, Michael Specka, et al.Psychiatrische Praxis|July 23, 2003
[Descriptive analysis of drug-related deaths over a 5-year period]Eugen Davids, Uwe Reinhold, Clemens Rösinger, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 16, 2006
A pilot clinical trial of oxcarbazepine in adults with attention-deficit hyperactivity disorderEugen Davids, Bernhard Kis, Michael Specka, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 8, 2005
History of attention-deficit hyperactivity disorder symptoms and opioid dependence: a controlled studyEugen Davids, Ulla von Bünau, Michael Specka, et al.The Psychiatric Quarterly|March 14, 2007
Changes in the treatment of acute psychosis in a German public hospital from 1998 to 2004Tiemo Wessels, Dandy Grünler, Christa Bunk, et al.European Archives of Psychiatry and Clinical Neuroscience|January 4, 2007
Neuropsychological assessment of adult patients with attention-deficit/hyperactivity disorderBernhard W Müller, Karla Gimbel, Anett Keller-Pliessnig, et al.Pageof 8